These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7481623)

  • 1. [Epidemiology of antibiotic resistance: implications for empirical treatment in intensive care].
    Wolff M
    Schweiz Med Wochenschr; 1995 Sep; 125(36):1684-6. PubMed ID: 7481623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia.
    Combes A; Luyt CE; Trouillet JL
    Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiology and drug resistance mechanisms of fully resistant pathogens.
    Walsh FM; Amyes SG
    Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
    Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
    Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
    J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-resistant bacteria in clinical situations].
    Watanabe A
    Rinsho Byori; 2000 Jan; Suppl 111():9-16. PubMed ID: 10804787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
    Paterson DL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S43-8. PubMed ID: 16894514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance: implications for managing respiratory failure.
    Chenoweth C; Lynch JP
    Curr Opin Pulm Med; 1997 Mar; 3(2):159-69. PubMed ID: 9193863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of healthcare-associated pneumonia (HCAP).
    Zilberberg MD; Shorr AF
    Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic resistance--bacteria fight back].
    Tambić Andrasević A
    Acta Med Croatica; 2004; 58(4):245-50. PubMed ID: 15700679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.